Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$1.92 - $4.1 $586,901 - $1.25 Million
-305,678 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$3.39 - $4.61 $487,363 - $662,756
-143,765 Reduced 31.99%
305,678 $1.32 Million
Q2 2018

Aug 14, 2018

BUY
$1.89 - $4.95 $647,326 - $1.7 Million
342,501 Added 320.27%
449,443 $1.77 Million
Q1 2018

May 15, 2018

BUY
$2.06 - $2.38 $220,300 - $254,521
106,942 New
106,942 $221,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.